Woodline Partners »

Lineage shares owned by Woodline Partners

Quarter-by-quarter ownership of Lineage shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Lineage

Tip: Access up to 7 years of quarterly data

All positions including Lineage held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 310k 78.38

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Lineage

BlackRock
T. Rowe Price Associates
Capital World Investors
Victory Capital Management
Principal Financial Group
Baillie Gifford & Co
Citadel Advisors
Centersquare Investment Management
Geode Capital Management
Capital Research Global Investors
Alyeska Investment Group
Goodman & Company, Investment Counsel
Healthcare Of Ontario Pension Plan Trust Fund
Invesco
Daiwa Securities Group

View all funds holding Lineage